Jinfang Pharmaceuticals-B (02595.HK) completes the issuance of 13.6 million shares of allocated stocks.

Intelligent Finance News App: Jingfang Pharmaceutical-B (02595.HK) announced that all conditions specified in the placement agreement have been met, and delivery was made on July 17, 2026, in accordance with the terms of the placement agreement. The placement agent successfully placed a total of 13.6 million shares at a price of HK$34.69 per share to no fewer than six subscribers, representing approximately 3.87% of the H shares issued after the issuance and expansion of the placement shares, and 3.54% of the total number of shares issued as of the date of this announcement.